GeraldHSokolMD

Radiation Oncology • New Port Richey, FL

Oncology @ fl cancer specialist, FDA

Join to view full profile

Dr. Sokol is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sokol's full profile

Already have an account?

Office
Florida Cancer Specialists (PRY)
8763 River Crossing Blvd
New Port Richey, FL 34655
Phone+1 727-842-8411

Fax+1 877-917-2336
Is this information wrong?

Education & Training

Massachusetts General HospitalResidency, Internal Medicine, 1976 - 1977
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1975 - 1976
Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 1974 - 1975
Massachusetts General HospitalResidency, Internal Medicine, 1973 - 1974
Homewood Hospital Center - North CampusResidency, Internal Medicine, 1971 - 1973
Temple University HospitalInternship, Internal Medicine, 1970 - 1971
Indiana University School of MedicineClass of 1970

Certifications & Licensure

FL State Medical License 1975 - 2026
AZ State Medical License 1975 - 2025
MD State Medical License 1971 - 2025
CO State Medical License 2022 - 2025
DC State Medical License 1987 - 2024
CA State Medical License 1975 - 2024
NJ State Medical License 1975 - 2017
MA State Medical License 1973 - 2011
LA State Medical License 1976 - 2000
PA State Medical License 1975 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
American Board of Radiology Therapeutic Radiology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2014

Publications & Presentations

PubMed

4 citations
Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer.
Benjamin A Gartrell, Mack Roach 3rd, Gerald H Sokol, Giuseppe Del Priore, Howard I Scher, Retter, A.> ;Investigational New Drugs. 2021 Apr 1
4 citations
Breast Cancer Survivorship: Patient Characteristics and Plans for High-Quality Care.
Loretta S Loftus, G. Sokol, Christine Laronga> ;Southern Medical Journal. 2017 Oct 1
11 citations
Intraoperative radiotherapy for early breast cancer and age: clinical characteristics and outcomes
Andrea M. Abbott, Lesly A. Dossett, Loretta Loftus, Weihong Sun, William J. Fulp, G. Sokol, Christine Laronga> ;American Journal of Surgery. 2015 Oct 1
A review of pharmaceutical labeling for overdose treatment and toxicity data.
Mazer-Amirshahi, M.,Sokol, G.,van den Anker, J.,Cantilena, L.> ;Pharmacoepidemiol Drug Saf. 2013 Mar
Systemic therapy for bone metastases.
Loftus, L. S., Edwards-Bennett, S., Sokol, G. H.> ;Cancer Control. 2012 Apr
686 citations
Sarcopenia With Limited Mobility: An International Consensus
John E. Morley, Angela Marie Abbatecola, Josep M. Argilés, Vickie E. Baracos, Juergen M. Bauer, Shalender Bhasin, Tommy Cederholm, Andrew J.S. Coats, Steven R. Cumming...> ;Journal of the American Medical Directors Association. 2011 Jul 1
44 citations
Potential Glucosamine‐Warfarin Interaction Resulting in Increased International Normalized Ratio: Case Report and Review of the Literature and MedWatch Database
James F. Knudsen, Gerald H. Sokol> ;Pharmacotherapy. 2008 Apr 1
1995 citations
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTR...
Mack Roach, Gerald E. Hanks, Howard D. Thames, Paul F. Schellhammer, William U. Shipley, Gerald H. Sokol, Howard M. Sandler> ;International Journal of Radiation Oncology, Biology, Physics. 2006 Jul 15
Reply to the Vioxx debacle.
J. F. Knudsen, Gerald H. Sokol> ;The American Journal of Medicine. 2006 Jan 1
The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.
Knudsen, J.F., Carlsson, U., Hammarström, P., Sokol, G.H., Cantilena, L.R.> ;Inflammation. 2004 Oct
41 citations
U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic Acid
Martin H. Cohen, Ramzi Dagher, Donna Griebel, Amna Ibrahim, Alison Martin, Nancy S. Scher, Gerald H. Sokol, Grant A. Williams, Richard Pazdur> ;The Oncologist. 2002 Oct 1
Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy.
Knudsen, J. F., Sokol, G. H., Flowers, C. M.> ;J Clin Pharm Ther. 2008 Oct 01
Join now to see all

Press Mentions

Gerald H. Sokol, MD, a Radiation Oncologist with Florida Cancer SpecialistsSeptember 25th, 2019

Hospital Affiliations

AdventHealth North PinellasTarpon Springs, Florida
Morton Plant North Bay HospitalNew Port Richey, Florida
HCA Florida Bayonet Point HospitalHudson, Florida
Bravera Health BrooksvilleBrooksville, Florida
Tampa General HospitalTampa, Florida
James A. Haley Veterans' Hospital-TampaTampa, Florida
George Washington University HospitalWashington, District of Columbia
Parrish Medical CenterTitusville, Florida